Used in research settings as a selective inhibitor of the enzyme fatty acid amide hydrolase (FAAH), enhancing endocannabinoid signaling. This property makes it valuable in studying pain modulation, inflammation, and neurological disorders. Commonly applied in preclinical models to evaluate potential therapies for anxiety, depression, and chronic pain conditions. Its specificity allows for targeted investigation of FAAH-related pathways without broad psychoactive effects. Often utilized in pharmacokinetic and pharmacodynamic studies to assess enzyme inhibition efficiency and duration of action in vivo.